ADEDAPO ODUWOLE: Open Payments
NPI 1720139645 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,362 in 121 payments from 12 companies in 2025. Trend: 2023 $17,489 · 2024 $12,250 · 2025 $9,362
Speaker / faculty: $6,750Food & beverage: $2,591Travel & lodging: $21
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $7,436 |
| Vanda Pharmaceuticals Inc. | 13 | $413 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $323 |
| Otsuka America Pharmaceutical, Inc. | 12 | $310 |
| Teva Pharmaceuticals USA, Inc. | 8 | $236 |
| Neurocrine BioSciences, Inc. | 8 | $217 |
| E.R. Squibb & Sons, L.L.C. | 11 | $197 |
| Lundbeck LLC | 5 | $134 |
| Alkermes, Inc. | 2 | $43 |
| Noven Therapeutics, LLC | 1 | $25 |
Products named: VRAYLAR, REXULTI, CAPLYTA, HETLIOZ, INGREZZA, COBENFY, UZEDY, FANAPT.
Industry payments across SC — which companies pay providers there.
